• Nenhum resultado encontrado

Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.

N/A
N/A
Protected

Academic year: 2016

Share "Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates."

Copied!
11
0
0

Texto

Loading

Referências

Documentos relacionados

A study of the RCT control group on the efficacy of the second dose of BCG vaccine in Brazilian school-aged children demonstrated that the protective efficacy of neonatal BCG

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children.. Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M,

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy Brazilian infants. Bernstein DI, Sander DS, Smith VE,

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy

Re- combinant, chimeric live, attenuated vaccine (Chimerivax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes

The animals were divided into several groups, received the first vaccine dose with modified live virus vaccine (ERA strain) and were revaccinated with inactivated virus or modified

We have demonstrated that moderately malnourished children do not suffer in- creased morbidity and do respond as suc- cessfully as their normal cohort in

(2011) Evaluation of Protective Efficacy of Respiratory Syncytial Virus Vaccine against A and B Subgroup Human Isolates in Korea.. This is an open-access article distributed under